Orthopediatrics Corp (KIDS) is an industry-leading medical device company primarily focused on developing treatments for children and adolescents with orthopedic conditions. Headquartered in Warsaw, Indiana, Orthopediatrics Corp. was founded in 2007 with the sole aim to provide the highest quality orthopedic implants and instruments specifically designed for pediatric patients, in an era when the sector was mainly focused on adults.
The company's commitment towards their mission, "Helping children with orthopedic conditions lead healthy, active lives", is reflected in their diversified product portfolio, with over 35 product systems developed exclusively for the pediatric orthopedic market. These products cover a wide spectrum of needs, targeting trauma and deformity, scoliosis, sports medicine and other clinical specialties.
Orthopediatrics Corp has cemented its position globally, with strong distribution networks in over 40 countries. Partnering with leading healthcare professionals, they have pioneered innovative solutions for complex medical conditions with their cutting-edge products, revolutionizing pediatric orthopedic care. The company's continuous focus on improvement, research and patient care has allowed them to achieve this influential status in a niche market.
Their success traces back to the dedicated team of experienced management, innovative engineers, adept clinicians and a skilled sales force who have collective years of experience and expertise in the orthopedic industry. This team's commitment to uphold the highest standards of quality, ethics and patient care is fundamentally structured on benefiting younger patients.
Moreover, as part of its commitment towards improving pediatric orthopedic care, the corporation actively invests in clinical education. Orthopediatrics Corp. offers a range of educational activities, from resident programs and surgeon fly-ins to hands-on cadaver courses, aiming to educate and diligently provide precise solutions to pediatric orthopedic issues.
In addition to their ethical product development, the corporation is part of numerous philanthropic initiatives such as funding non-profits that sponsor pediatric surgeries, and sponsoring medical mission trips. This expands their corporate social responsibility while also broadening the impact of their mission.
Over the years, Orthopediatrics Corp. has demonstrated a solid growth trajectory, a trend backed up by strong financial performance and market reception. The company operates publicly under the NASDAQ symbol ‘KIDS’. It continues to forge on its growth and innovation path
while staying true to its vision of improving the lives of children.
While acknowledging the reputation and achievements of Orthopediatrics Corp, one cannot overlook the exceptional specialization of this company. It stands unique with its requisite focus on pediatric orthopedic care, reflecting its commitment to enhancing the quality of life for this specific demographic, and further validating that ‘kids’ aren’t merely part of their name, but a true representation of their cause.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends

OrthoPediatrics Corp. (Nasdaq: KIDS) has announced that its Pediatric Nailing Platform (PNP) Tibia System has surpassed 1,000 implantations. This system, specifically designed for pediatric patients, includes a unique 7mm cannulated rigid tibial nail, which allows treatment for patients previously untreatable with adult systems. The rapid adoption highlights OrthoPediatrics' success in addressing a critical need in pediatric orthopedic implant offerings.

Orthopediatrics Corp. (NASDAQ: KIDS) is currently exhibiting weak near and mid-term sentiment, despite a strong long-term positive outlook. AI models have identified a mid-channel oscillation pattern and an exceptional short setup with a high risk-reward ratio, targeting a 12.7% downside with 0.3% risk. The article details specific trading strategies for different risk profiles, including long, breakout, and short positions, alongside multi-timeframe signal analysis.
_07_03_2026_03_50_21_133108.jpg)
ORTHOPEDIATRICS CORP (NASDAQ: KIDS) Director David Pelizzon sold 22,500 shares of the company's stock at $23.35 per share on September 2, 2026. Following this transaction, Pelizzon's total ownership in KIDS stock is 6,504,133 shares. This sale provides investors with updated insight into his stake and the transaction details.
Squadron Capital LLC, a significant owner of Orthopediatrics Corp (NASDAQ:KIDS), recently sold 22,500 shares totaling $525,375 to provide capital for other portfolio businesses. This transaction occurred on September 2, 2026, with shares sold at a weighted average price of $23.35, though the stock is currently trading lower at $22.41. Despite the sale and an "overvalued" assessment by InvestingPro, OrthoPediatrics recently reported strong Q2 revenue growth and an increased full-year outlook.

OrthoPediatrics Corp Director Jennifer N. Pritzker, through Squadron Capital LLC, sold 22,500 shares of the company's common stock on September 2, 2026. The shares were sold at a weighted average price of $23.35, generating capital for Squadron Capital LLC's other portfolio companies. Following the transaction, Squadron Capital LLC indirectly beneficially owns 6,504,133 shares.

OrthoPediatrics has announced the full commercial launch of its 3P™ Pediatric Plating Platform® Hip System in the United States, following a successful limited launch period with over 350 surgical implantations. This system is the first in their Pediatric Plating Platform portfolio and is designed to advance trauma and deformity correction in pediatric orthopedics, offering enhanced fixation options and streamlined workflow. The company aims for this system to establish the foundation for a comprehensive and technologically advanced plating portfolio.